This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Herbalife Circus: Expect More Entertainment (Update1)

(Updated from 11:06 a.m. EST to include comments from Icahn on CNBC in the 15th and 16th paragraphs.)

NEW YORK ( TheStreet) -- Let the games begin.

Just a month after their very public battle on CNBC, the fight between Carl Icahn and Bill Ackman just ratcheted up another level, with Icahn revealing he has close to a 13% stake in Herbalife (HLF - Get Report).

Icahn filed a 13D on Thursday, showing he has accumulated a stake in the multi-level marketing (MLM) company. The interesting part is that it's mostly in options, and the majority of it was accumulated this week, in anticipation of a deluge of regulatory filings.

In the filing, Icahn noted that Herbalife "has a legitimate business model, with favorable long-term opportunities for growth. The Reporting Persons [Icahn] intend to have discussions with management of the Issuer regarding the business and strategic alternatives to enhance shareholder value, such as a recapitalization or a going-private transaction."

Ackman, through his Pershing Square Capital Management hedge fund, is short some 20 million shares of the company, which he called a fraud last year. Ackman has even gone so far as to set up a Web site devoted to his thesis on the company, factsaboutherbalife.com.

The short position caused Herbalife to respond last month, with executives calling the claims false. "The allegation that Herbalife is a pyramid scheme is bogus. Make no mistake: Today's announcement isn't about Herbalife's business model. It's about Bill Ackman's business model," the company said in a statement.

The Wall Street Journal reported last month that the Securities and Exchange Commission has opened an inquiry into Herbalife.

Herbalife CEO Michael O. Johnson has appeared repeatedly on CNBC to defend his firm, which he has described as a "legitimate company." Then there was this bizarre statement from Herbalife demanding a correction from the NY Post last month. It's become a circus, except now we have billionaires involved, instead of Barnum & Bailey.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
HLF $55.54 0.82%
AAPL $126.60 0.94%
FB $86.91 1.34%
GOOG $521.84 0.26%
TSLA $269.15 0.33%

Markets

DOW 17,757.91 +138.40 0.79%
S&P 500 2,077.42 +14.31 0.69%
NASDAQ 5,013.1230 +26.2560 0.53%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs